|
AMRX Amneal Pharmaceuticals Inc 1723128 |
| Balance Sheet |
|
Current Assets
|
$1,947,029,000.00 |
|
Assets
|
$3,776,348,000.00 |
|
Current Liabilities
|
$883,187,000.00 |
|
Equity
|
$33,024,000.00 |
|
Shares Out
|
319353919.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-47,987,000.00 |
|
Investing Cash Flow
|
$-144,452,000.00 |
| Market Analysis |
Market Cap
|
$5,716,435,150.10 |
|
Price
|
$17.90 |
|
BVPS
|
0.10 |
|
PB
|
179.00 |
|
EPS
|
0.18 |
|
PE
|
46.19 |
|
PS
|
1.79 |
|
FCF
|
$-86,859,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:15 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-27 |
0.21 |
|
| Apr |
May |
Jun |
|
|
2026-04-22 |
0.27 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
0.25 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-30 |
0.17 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AMRX documents filed with the SEC.
AMRX Filings
Clear
